Critical Comparison: Nihon Kohden (OTCMKTS:NHNKY) versus Bionik Laboratories (OTCMKTS:BNKL)

Bionik Laboratories (OTCMKTS:BNKL) and Nihon Kohden (OTCMKTS:NHNKY) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, earnings, institutional ownership, analyst recommendations, risk and profitability.

Analyst Recommendations

This is a summary of recent recommendations for Bionik Laboratories and Nihon Kohden, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Bionik Laboratories	0	0	0	0	0.00
Nihon Kohden	0	0	0	1	4.00

Given Bionik Laboratories’ higher possible upside, research analysts plainly believe Bionik Laboratories is more favorable than Nihon Kohden.

Valuation and Earnings

This table compares Bionik Laboratories and Nihon Kohden”s gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Bionik Laboratories	$1.80 million	N/A	-$4.95 million	($0.38)	N/A
Nihon Kohden	$1.48 billion	1.13	$93.05 million	$0.51	19.25

Nihon Kohden has higher revenue and earnings than Bionik Laboratories. Bionik Laboratories is trading at a lower price-to-earnings ratio than Nihon Kohden, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Bionik Laboratories and Nihon Kohden’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Bionik Laboratories	N/A	N/A	N/A
Nihon Kohden	5.32%	7.25%	5.12%

Insider and Institutional Ownership

0.1% of Nihon Kohden shares are owned by institutional investors. 40.4% of Bionik Laboratories shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Nihon Kohden beats Bionik Laboratories on 9 of the 11 factors compared between the two stocks.

About Bionik Laboratories

Bionik Laboratories Corp., a robotics company, engages in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. It offers InMotion Robots, which include a suite of robotic rehabilitation products; InMotion ARM, an evidence-based intelligent interactive rehabilitation technology that senses patient movements and limitations; InMotion ARM/HAND, which provides support for therapy involving reaching with grasp and release movements, and individual hand movements; and InMotion Connect platform that consists of a hardware device connected to the InMotion Robot, as well as a subscription to InMotion Connect Pulse. Bionik Laboratories Corp. was incorporated in 2010 and is headquartered in Watertown, Massachusetts.

About Nihon Kohden

Nihon Kohden Corporation engages in development, manufacturing, sale, maintenance, and consultation of medical electronic equipment, and related systems and products in Japan, Americas, Europe, rest of Asia, and internationally. It offers physiological measuring equipment comprising electrocardiographs, electroencephalographs, and polygraphs for Cath-labs; patient monitoring systems, such as beside and central monitors; and treatment equipment including defibrillators, automated external defibrillators, ventilators, and pacemakers. The company also provides medical support system, which includes diagnostic and clinical information system; and in-vitro diagnostic equipment comprising hematology and clinical chemistry analyzers. In addition, it operates insurance brokerage and technology licensing business. The company was incorporated in 1951 and is headquartered in Shinjuku, Japan.